Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00454805
Status:
COMPLETED
Last Update Posted:
2016-08-03
First Post:
2007-03-29
Brief Title:
AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer
Sponsor:
Organization:
AstraZeneca